25 research outputs found
Epleyâs maneuver versus Semontâs maneuver in treatment of posterior canal benign positional paroxysmal vertigo
Background: Benign paroxysmal positional vertigo (BPPV) is characterized by brief but violent attacks of paroxysmal vertigo provoked by certain positions of the head. BPPV is the most common cause of vertigo, resulting from migration of otoconia into the semicircular canals. Majority of patients have posterior canal BPPV. Epleyâs Canalith Repositioning and Semont Liberatory Maneuver have been shown to be highly efficacious in the successfultreatment of posterior canal BPPV. The main objective of this study was to compare the efficacy of Epleyâs maneuver versus Semontâs maneuver in the management of benign paroxysmal positional vertigo.Methods: This study was conducted in the Department of Otorhinolaryngology of a rural Medical College in Kerala, for a period of one and half year, from January 2015 to June 2016. It was an observational prospective cohort study. 200 patients with posterior canal BPPV were enrolled in this study based on inclusion and exclusion criteria. Patients were allotted alternatively to Epleyâs group and Semontâs group, 100 patients in each group based on the treatment maneuvers they underwent. Efficacy of maneuvers were assessed at the end of 1st week, 1st month and 3rd month on the basis of resolution of symptoms and Dix-Hallpike negativity.Results: Of the 100 cases managed by Epleyâs maneuver 95 cases showed complete relief of symptoms after 3 months. Out of 100 cases managed by Semontâs maneuver, 94 cases showed complete recovery after 3 months. The results were compared by Chi square test, as the data was mainly qualitative in nature. The results of both the groups were compared at the end of 1st week, 1st month and 3rd month, which revealed that both the Semontâs and Epleyâs maneuver are equally effective in the treatment of posterior canal BPPV.Conclusions: Both Epleyâs and Semontâs maneuver are equally effective for treating the patients of posterior canal benign paroxysmal positional vertigo
First simulation study of trackless events in the INO-ICAL detector to probe the sensitivity to atmospheric neutrinos oscillation parameters
The proposed India-based Neutrino Observatory will host a 50 kton magnetized
iron calorimeter (ICAL) with resistive plate chambers as its active detector
element. Its primary focus is to study charged-current interactions of
atmospheric muon neutrinos via the reconstruction of muons in the detector. We
present the first study of the energy and direction reconstruction of the final
state lepton and hadrons produced in charged current interactions of
atmospheric electron neutrinos at ICAL and the sensitivity of these events to
neutrino oscillation parameters and . However,
the signatures of these events are similar to those from neutral-current
interactions and charged-current muon neutrino events in which the muon track
is not reconstructed. On including the entire set of events that do not produce
a muon track, we find that reasonably good sensitivity to is
obtained, with a relative precision of 15% on the mixing parameter
, which decreases to 21%, when systematic uncertainties are
considered
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients
Student Traveler : Letâs Explore Indonesia
Learning English is a must-have skill, particularly for the millennial generation, which will compete globally with people from all over the world. Mastering English is no longer a choice; it is an unavoidable must. Language, particularly English, serves as a portal to the rest of the world. Reading and writing are essential skills for all students, especially as they strive to become more insightful students who will be fully useful and knowledgeable human beings in the future. As a result, students will have the insight and knowledge necessary to construct and govern this country as future leaders.
Writing, in addition to reading, is a requirement for demonstrating studentsâ linguistic competence. Writing is one of our methods for ensuring the survival and continuance of our information. This book chapter includes information that will help everyone to travel either all around Indonesia or the world
The international WAO/EAACI guideline for the management of hereditary angioedema â The 2021 revision and update
© 2022 The Author(s)Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.N